Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy — Stella

Recruiting

Back to Prostate Cancer (Diagnosis) trials

Trial locations(3 sites)

Germany

Klinik für Strahlentherapie, Augsburg, Bavaria

Strahlenklinik Erlangen, Erlangen, Bavaria

Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Munich, Bavaria

Key details

Sponsor

University of Erlangen-Nürnberg Medical School

Collaborators

Bavarian Cancer Research Center (BZKF), University Hospital Augsburg

Enrollment target

~200 participants

Started

December 2025

Primary completion

July 2028

Age range

18 Years and older

Sex

Male only

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov